arrow
N

Neeraj Narula

mcmaster university
H指数:41
被引数:7,512

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study

难治性炎症性肠病或合并免疫介导性疾病或肠外表现的患者的先进联合治疗的有效性和安全性:一项多中心加拿大研究

2026-02-013
PRE
Patients with ulcerative colitis that have endoscopic Mayo score 1 and active histologic inflammation have similar outcomes to mild-moderate patients with Mayo score 2: a post hoc analysis of the VARSITY trial

溃疡性结肠炎患者内镜梅奥评分1分且伴有活动性组织学炎症者,其结局与梅奥评分2分的轻中度患者相似:VARSITY试验的事后分析

2026-01-010
PRE
Nationalization of clinical care pathways for inflammatory bowel disease management in Canada

加拿大炎症性肠病管理临床护理路径的标准化

2026-01-010
PRE
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review

机器学习模型在评估溃疡性结肠炎试验终点中的梅奥内镜评分:一项系统评价

2025-11-010
PRE
Drug Discontinuation and Persistent Symptoms Among Initiators of Bio-Originator and Biosimilar anti-Tumor Necrosis Factor Drugs in Inflammatory Bowel Disease: Real-World Contemporary Data From the CAnadian Network for Advanced Interdisciplinary Methods/CIRC Registry

炎症性肠病患者中生物原研药和生物类似药抗肿瘤坏死因子药物启动者的停药与持续性症状:来自加拿大跨学科高级方法网络/CIRC注册系统的当代真实世界数据

2025-11-010
OAAI
European Crohn's and Colitis Organisation consensus on dietary management of inflammatory bowel disease

Svolos, V.; Gordon, H.; Lomer, M.C.E.; Aloi, M.; Bancil, A.; Day, A.S.; Day, A.S.; Fitzpatrick, J.A.; Gerasimidis, K.; Gkikas, K.; 等. ECCO关于炎症性肠病饮食管理的共识. J. Crohns Colitis 2025, jjaf122. [Google Scholar] [CrossRef]

2025-09-0110
OAAI